The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation.
about
Transcriptional Reactivation of the FMR1 Gene. A Possible Approach to the Treatment of the Fragile X SyndromeChallenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of KnowledgeA chromatin-dependent role of the fragile X mental retardation protein FMRP in the DNA damage responseTudor Domain Containing Protein 3 Promotes Tumorigenesis and Invasive Capacity of Breast Cancer CellsA feed-forward mechanism involving Drosophila fragile X mental retardation protein triggers a replication stress-induced DNA damage responseHigh-Throughput Screening to Identify Compounds That Increase Fragile X Mental Retardation Protein Expression in Neural Stem Cells Differentiated From Fragile X Syndrome Patient-Derived Induced Pluripotent Stem Cells.Biphasic and Stage-Associated Expression of CPEB4 in Hepatocellular Carcinoma.A novel link between FMR gene and the JNK pathway provides clues to possible role in malignant pleural mesothelioma.Retracted: Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566.Necrotic cells influence migration and invasion of glioblastoma via NF-κB/AP-1-mediated IL-8 regulation.Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissueAugmented noncanonical BMP type II receptor signaling mediates the synaptic abnormality of fragile X syndrome.MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4.Fragile X mental retardation protein promotes astrocytoma proliferation via the MEK/ERK signaling pathway.RNA-binding proteins as molecular links between cancer and neurodegeneration.Rethinking pheochromocytomas and paragangliomas from a genomic perspective.Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review.Sustained expression of FMR1 mRNA from reactivated fragile X syndrome alleles after treatment with small molecules that prevent trimethylation of H3K27.RNA G-quadruplexes: emerging mechanisms in diseaseAging in Fragile X Premutation Carriers.Molecular mechanisms of mTOR regulation by stressThe MAP kinase-interacting kinases regulate cell migration, vimentin expression and eIF4E/CYFIP1 binding.hnRNP A1-mediated translational regulation of the G quadruplex-containing RON receptor tyrosine kinase mRNA linked to tumor progression.The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cells.FMRP regulates multipolar to bipolar transition affecting neuronal migration and cortical circuitry.Mothers of Children with Autism have Different Rates of Cancer According to the Presence of Intellectual Disability in Their Child.GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor Growth.Targeted Reactivation of Transcription in Fragile X Syndrome Embryonic Stem CellsThe Intracellular Cleavage Product of the NG2 Proteoglycan Modulates Translation and Cell-Cycle Kinetics via Effects on mTORC1/FMRP Signaling
P2860
Q26739927-E63C5F96-9AAA-4DDA-A1BC-14D613BDB2BFQ28069766-65439757-EA20-4FFE-9EEF-D49AC2510821Q28117547-1A2EAEBF-C211-4F7D-BCB2-89A01D5339EBQ33894997-BB6D2CC6-9EC0-4556-B948-A1776FB43A4EQ34155406-AE91D11B-34E2-4EAD-B53C-24362880A5A4Q35638949-228A3193-E557-4698-B904-12BA7349C16EQ36012026-90BD2A6A-7552-4CE5-923E-C653B869F549Q36042626-0558DE1F-7E0F-4771-BB5E-052C05A37A0AQ36283892-CFAF0063-28B9-4DD0-B521-A7E930C37F20Q36796276-6E35C66C-47B1-4890-9908-BAB9C875C9FBQ36925690-F723A663-647E-4756-8F4F-57BEDAADF822Q37611383-D529ABCB-33D6-4EA5-9FF3-4A64A64C8237Q37688166-A589CCF2-365F-4846-BCA4-395584E4F71AQ37688952-F77C5AB0-1BEB-4DE0-909E-E37AD252068AQ38251313-C022B100-D2E0-45AB-99E4-1FCB0BF03A7FQ38509463-CC7F5534-6361-484A-95D8-7BD3F429A30CQ38538492-84628053-7EDB-4804-B3BB-92A09D8B6CEBQ38759837-5225D3E6-5ADD-4D97-B98E-0067C61BA6BFQ38778353-756DD2FF-E93A-4224-B091-CC90FAF425B4Q38849578-2788EBB0-FB05-4A21-B633-F759BFF86A52Q38866763-37D2DF61-36DF-4205-B63D-2FD58B7A4243Q38920048-F9929A3E-7431-4F91-BB2F-B3F6C0A19506Q41962611-4FF926E8-5F05-48A4-A5ED-BF7C643B7716Q47396492-2AC4979E-C192-4F92-AAD5-CC26B171B19BQ48454676-E4F39ADB-65A4-42E5-9432-A97059F95A03Q50302859-EFA11AD0-EDC3-444F-AB02-79177AF65C6AQ55322458-0F007173-27C4-4677-A3F2-5E67BCAD5B3AQ58777280-136A6F5C-041E-480B-B030-83BB76ADDD3AQ58797194-1F756AFE-C9CA-4A61-A430-00083B32F368
P2860
The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The fragile X protein binds mR ...... odulates metastasis formation.
@en
The fragile X protein binds mR ...... odulates metastasis formation.
@nl
type
label
The fragile X protein binds mR ...... odulates metastasis formation.
@en
The fragile X protein binds mR ...... odulates metastasis formation.
@nl
prefLabel
The fragile X protein binds mR ...... odulates metastasis formation.
@en
The fragile X protein binds mR ...... odulates metastasis formation.
@nl
P2093
P2860
P50
P356
P1476
The fragile X protein binds mR ...... odulates metastasis formation.
@en
P2093
Anna Kuchnio
Fabrizio Bianchi
Franca Del Nonno
Giorgio La Fata
Giovanni Neri
Marco Bianchi
Maria Giulia Farace
Mauro Piacentini
Michele Averna
Patrick Neven
P2860
P304
P356
10.1002/EMMM.201302847
P50
P577
2013-09-16T00:00:00Z